3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
39
Neoplasms
37
Depression
29
Prostatic Neoplasms
23
Fatigue
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, Large B-Cell, Diffuse
13
Carcinoma, Non-Small-Cell Lung
13
Anxiety Disorders
13
Lymphoma, Mantle-Cell
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Burkitt Lymphoma
12
Pain
11
Lymphoma, Non-Hodgkin
11
Lymphoma, B-Cell, Marginal Zone
11
Lung Neoplasms
11
Lymphoma, Large-Cell, Immunoblastic
10
Leukemia, Myeloid, Acute
10
Colorectal Neoplasms
10
Leukemia, Myeloid, Chronic-Phase
9
Hodgkin Disease
9
Blast Crisis
9
Vomiting
8
Nausea
8
Lymphoma
8
Leukemia, Myeloid, Accelerated Phase
8
Head and Neck Neoplasms
8
Uterine Cervical Neoplasms
7
Interventions
Doxorubicin
16
Zidovudine
13
Vincristine
12
Bleomycin
11
Interferon alpha-2
6
Cyclophosphamide
6
Methotrexate
5
Liposomes
5
Leucovorin
5
Dexamethasone
5
tecogalan
4
sargramostim
4
Filgrastim
4
Etoposide
4
Cytarabine
4
Ritonavir
3
Nivolumab
3
Fluorouracil
3
pomalidomide
2
liposomal doxorubicin
2
interferon alfa-n1
2
Watchful Waiting
2
Valganciclovir
2
Tumor Necrosis Factor-alpha
2
Tobacco Use Cessation Devices
2
Thalidomide
2
Surveys and Questionnaires
2
Rituximab
2
Paclitaxel
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Acquired Immunodeficiency Syndrome
×
Therapeutics
×
Clear all
NCT02615860
2022-11-08
TECAIN
University Hospital, Essen
Phase NA
Completed
560 enrolled